Asthma

Exploring the perspectives of health care professionals, researchers test the feasibility of the Asthma Care from Home project.

Through the perspectives of US health care plans and payers, researchers explore the differences in cost between single maintenance and reliever therapy and traditional therapies for treating asthma.

Despite a significant leap in the development of asthma therapies, depression symptoms continue to be a roadblock for improved outcomes.

With a multitude of concerns surrounding corticosteroids for asthma, researchers explore the overall clinical and economic burden of these drugs.

Pharmacists enhance asthma care by bridging knowledge gaps, improving medication adherence, and providing cost-effective treatment options for patients.

Dietary nutrients show promise in reducing asthma risk linked to indoor air pollution, offering new strategies for pharmacists in patient care.

A recent review highlights cardiovascular risks linked to albuterol use in asthma treatment, urging safer alternatives and enhanced patient monitoring strategies.

A recent study reveals a heightened stroke risk in asthma patients recovering from severe COVID-19, emphasizing the need for proactive monitoring and management.